MetLife Investment Management’s Chimera Investment CIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$556K Buy
44,273
+2,020
+5% +$26.3K ﹤0.01% 1696
2025
Q4
$525K Sell
42,253
-6,181
-13% -$78.5K ﹤0.01% 1777
2025
Q3
$640K Hold
48,434
﹤0.01% 1690
2025
Q2
$672K Hold
48,434
﹤0.01% 1534
2025
Q1
$621K Sell
48,434
-797
-2% -$11.2K ﹤0.01% 1607
2024
Q4
$689K Buy
49,231
+2,694
+6% +$40.4K ﹤0.01% 1617
2024
Q3
$737K Hold
46,537
﹤0.01% 1569
2024
Q2
$596K Buy
46,537
+13,467
+41% +$171K ﹤0.01% 1621
2024
Q1
$457K Sell
33,070
-7,679
-19% -$107K ﹤0.01% 1724
2023
Q4
$610K Hold
40,749
﹤0.01% 1573
2023
Q3
$667K Hold
40,749
0.01% 1458
2023
Q2
$705K Hold
40,749
0.01% 1473
2023
Q1
$689K Buy
40,749
+2,220
+6% +$42.5K 0.01% 1445
2022
Q4
$636K Sell
38,529
-3,197
-8% -$59.6K ﹤0.01% 1490
2022
Q3
$653K Buy
41,726
+1,404
+3% +$36.6K 0.01% 1444
2022
Q2
$1.07M Sell
40,322
-1,264
-3% -$37.5K 0.01% 1173
2022
Q1
$1.5M Buy
41,586
+15,932
+62% +$634K 0.01% 1114
2021
Q4
$1.16M Sell
25,654
-1,725
-6% -$81.6K 0.01% 1068
2021
Q3
$1.22M Hold
27,379
0.01% 1037
2021
Q2
$1.24M Buy
27,379
+5,633
+26% +$234K 0.01% 1061
2021
Q1
$829K Sell
21,746
-3,658
-14% -$125K 0.01% 1251
2020
Q4
$781K Hold
25,404
0.01% 1244
2020
Q3
$625K Sell
25,404
-3,236
-11% -$86.2K 0.01% 1254
2020
Q2
$826K Buy
+28,640
New +$736K 0.01% 1107
2019
Q2
Sell
-85
Closed -$4.78K 2460
2019
Q1
$4.78K Hold
85
﹤0.01% 2477
2018
Q4
$4.53K Hold
85
﹤0.01% 2470
2018
Q3
$4.64K Buy
+85
New +$4.78K ﹤0.01% 2532

Other funds holding CIM

MetLife Investment Management's CIM Position: Q1 2026 in Review

MetLife Investment Management increased its Chimera Investment (CIM) stake by 4.8% in Q1 2026, buying an estimated $26.3K and bringing the position to 44,273 shares worth $556K. The position accounts for ﹤0.01% of the portfolio, ranked #1696.

MetLife Investment Management first reported a position in CIM in Q3 2018 and has held it in 27 quarters since. The position peaked at $1.5M in Q1 2022. 198 funds tracked by Wall St. Rank hold CIM as of Q1 2026.

  • MetLife Investment Management held 44,273 shares of Chimera Investment worth $556K as of Q1 2026.
  • MetLife Investment Management bought 2,020 Chimera Investment shares in Q1 2026, an estimated $26.3K.
  • Chimera Investment made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #1696 holding.
  • MetLife Investment Management first reported a position in Chimera Investment in Q3 2018 and has held it in 27 quarters since.
  • MetLife Investment Management's Chimera Investment position peaked at $1.5M in Q1 2022.
  • 198 funds tracked by Wall St. Rank held Chimera Investment as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.